Lannett Company, Inc. (NYSE MKT: LCI) today reported continued strong momentum, with sharply improved financial results for its fiscal 2013 third quarter ended March 31, 2013, compared with the prior year period.
Read More

Lannett Company, Inc. (NYSE MKT: LCI) today announced that it expects to report fiscal 2013 third quarter net sales of approximately $39 million and diluted earnings per share between $0.12 and $0.14.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the Needham’s 12th Annual Healthcare Conference on Wednesday, May 1, 2013, at 2:20 p.m. ET at The Westin Grand Central Hotel, 212 East 42nd Street, New York.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the 25th Annual Roth Conference on Monday, March 18, 2013, at 9:30 a.m. PT ( 12:30 p.m. ET) at The Ritz-Carlton Hotel in Dana Point, California.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE MKT: LCI) today reported continued strong momentum, with sharply improved financial results for its fiscal 2013 second quarter ended December 31, 2012, compared with the prior year period.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE MKT: LCI) today announced that it expects to report net sales of approximately $36 million and diluted earnings per share between $0.08 and $0.10 for its fiscal 2013 second quarter ended December 31, 2012
Read More

Lannett Company, Inc. (NYSE MKT: LCI) today announced that the renewal of its universal shelf registration statement on Form S-3 was declared effective by the Securities and Exchange Commission (SEC) today.
Read More

Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the Oppenheimer 23nd Annual Healthcare Conference on Wednesday, December 12, 2012 at 1:35 p.m. ET at the Waldorf Astoria Hotel in New York City.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE MKT: LCI) today reported financial results for the fiscal 2013 first quarter ended September 30, 2012.
Read More

Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has made a donation to the American Red Cross to support Hurricane Sandy relief efforts.
Read More

Lannett Company, Inc. (NYSE MKT: LCI), today announced that the company will release its fiscal 2013 first quarter financial results on Thursday, November 8, 2012 after the market closes.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Butalbital, Acetaminophen and Caffeine Tablets, USP, 50mg/325mg/40mg.
Read More

Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the UBS Global Life Sciences Conference on Wednesday, September 19, 2012 at 11:30 a.m. ET (8:30 a.m. PT) at the Grand Hyatt New York Hotel.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE MKT: LCI) today reported financial results for the fiscal 2012 fourth quarter and full year ended June 30, 2012.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE MKT: LCI), today announced that the company will release its fiscal 2012 fourth-quarter and full-year financial results on Thursday, September 6, 2012 after the market closes.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that Jeffrey Farber, vice chairman of the board, has been named chairman, effective immediately, succeeding Ronald A. West, who is relinquishing the chairman position because of health reasons, but will remain on the board.
Read More

Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Paul Taveira to its board of directors, expanding the companys board to eight members.
Read More

Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2012 third quarter and nine months ended March 31, 2012.
Read More

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will release its fiscal 2012 third-quarter financial results on Tuesday, May 8, 2012 after the market closes.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the 24th Annual Roth OC Growth Stock Conference on Monday, March 12, 2012 at 3:30 p.m. PT ( 6:30 p.m. ET) at The Ritz-Carlton Hotel, Laguna Niguel, in Dana Point, California.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2012 second quarter and six months ended December 31, 2011.
Read More

Lannett Company, Inc. (NYSE AMEX: LCI), today announced that it has received approval from the U.S Food and Drug Administration (FDA) of its supplemental Abbreviated New Drug Application (ANDA) for Phentermine HCL Capsules, 15 mg.
Read More

Lannett Company, Inc. (NYSE AMEX: LCI), a manufacture of generic pharmaceuticals, today announced that the company will release its fiscal 2012 second-quarter financial results on Tuesday, February 7, 2012 after the market closes.
Read More
Listen To Audio Webcast

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
Read More

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA), regarding the design of a Phase III study of the companys Cocaine HCl topical solution product, C-Topical.
Read More

Lannett Company, Inc. (NYSE AMEX: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Triamterene with Hydrochlorothiazide 37.5/25mg Capsules.
Read More

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the Oppenheimer 22nd Annaul Healthcare Conference on Wednesday, December 14, 2011 at 11:25 a.m. ET at the Waldorf Astoria Hotel in New York City.
Read More
View the Webcast